TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 6 | 1 | -2 | 2 | 7 | 11 | 27 | 8 |
| S | %wins | 67 | 83 | 33 | 33 | 0 | 0 | 36 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/07 20:08 | 5/2/07 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Yang Taiyin | CA | O | SVP,Phar | S | -1,675 | 83.75 | 33 | -20 | -12 | 150 | D | 125 | 44 | 19 | 30 | 13 | 8 | 0 | -2 | 0 | -1 | -1 | -11 | 10 | 24 |
2/22/07 19:25 | 2/21/07 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Yang Taiyin | CA | O | SVP,Phar | S | -1,474 | 73.72 | 33 | -20 | -11 | 170 | D | 120 | 21 | 17 | 9 | 14 | 15 | 4 | 3 | -1 | -3 | 1 | 13 | 2 | 19 |
2/7/07 19:12 | 2/6/07 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Yang Taiyin | CA | O | SVP,Phar | S | -1,404 | 70.22 | 33 | -20 | -10 | 190 | D | 118 | 16 | 15 | 3 | 8 | 6 | 12 | -2 | 0 | -2 | -3 | 15 | 5 | 25 |
2/24/06 10:54 | 2/22/06 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Yang Taiyin | CA | O | SVP,Phar | S | -1,223 | 61.13 | 33 | -20 | -9 | 210 | b | 4 | 0 | 2 | -9 | 3 | 21 | ||||||||
11/23/05 20:26 | 11/22/05 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Yang Taiyin | CA | O | SVP,Phar | S | -1,080 | 53.99 | 33 | -20 | -13 | 131 | D | 90 | 57 | 34 | 32 | 17 | 11 | 0 | -1 | 1 | -6 | 3 | 15 | 4 | 24 |
8/31/05 21:23 | 8/31/05 | GILD | Gilead Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Yang Taiyin | CA | O | SVP,Phar | S | -421 | 42.10 | 33 | -10 | -6 | 151 | D | 24 | 19 | 17 | -1 | -12 | -1 | -3 | 1 | 0 | 1 | 11 | 21 | 44 | 50 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |